Journal of Hepatology · 2019 · 45 citations · 37 references
Hepatocellular carcinoma (HCC) is a heterogeneous disease associated with a poor prognosis. In patients with HCC, TLR3 downregulation is associated with reduced survival. Herein, we show that the absence of TLR3 is associated with a lower rate of apoptosis, and subsequently more rapid hepatocarcinogenesis, without any change to the immune infiltrate in the liver. Therefore, the poor prognosis associated with low TLR3 expression in HCC is likely linked to tumors ability to escape apoptosis. TLR3 may become a promising therapeutic target in TLR3-positive HCC.
37
Infection of a human hepatoma cell line by hepatitis B virus
Philippe Gripon, Sylvie Rumin, Stephan Urban et al. · Proceedings of the National Academy of Sciences · 2002 · 1.2K citations · Full text
Immunology, Hepatitis B, Pathology +18
mRNA Is an Endogenous Ligand for Toll-like Receptor 3
Katalin Karikó, Houping Ni, John Capodici et al. · Journal of Biological Chemistry · 2004 · 1K citations · Full text
Genome‐wide molecular profiles of HCV‐induced dysplasia and hepatocellular carcinoma†
Elisa Wurmbach, Ying‐Bei Chen, Greg Khitrov et al. · Hepatology · 2007 · 748 citations · Full text
TLR3 Can Directly Trigger Apoptosis in Human Cancer Cells
Bruno Salaun, Isabelle Coste, Marie‐Clotilde Rissoan et al. · The Journal of Immunology · 2006 · 469 citations · Full text